PyInvesting

Market research

600566.SHG Hubei Jumpcan Pharmaceutical Co., Ltd

SHG CNY Healthcare

Latest close

31.13 —

As of Nov 20, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
27B
P/E ratio
14.86
Analyst target
52.36
Dividend yield
6.0%
Beta
0.07

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Hubei Jumpcan Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 15.1% below its 200 day moving average.

From a valuation standpoint, the stock is 70.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.8.

Hubei Jumpcan Pharmaceutical Co., Ltd's total revenue sank by 7.9% to $1B since the same quarter in the previous year.

Its net income has dropped by 19.6% to $275M since the same quarter in the previous year.

Finally, its free cash flow fell by 76.1% to $132M since the same quarter in the previous year.

Based on the above factors, Hubei Jumpcan Pharmaceutical Co., Ltd gets an overall score of 1/5.